Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
Healthy Volunteers
NCT06545214

Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy

Led by Hospices Civils de Lyon · Updated on 2026-03-27

60

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

30% of patients with epilepsy suffer from drug-resistant seizures and are at risk of epilepsy-related complications, from cognitive dysfunctions to premature mortality. Both seizures and their complications are modulated by patients' vigilance states, with a tight and bi-directional interplay between sleep and epilepsy. Several epilepsy complications are associated with sleep, such as sleep-disordered breathing or Sudden and Unexpected Death in Epilepsy (SUDEP). SUDEP is a non-traumatic death, unrelated to a documented status epilepticus, which accounts for up 50% of premature deaths in epilepsy, with a cumulative risk of ≈ 10% at 40 years in patients with childhood-onset epilepsy. SUDEP typically occurs during sleep, after a nocturnal seizure, and primarily results from a postictal central respiratory dysfunction in patients with generalized convulsive seizure (GCS), suggesting that interaction between respiratory dysfunction and sleep state may play a role in its pathophysiology. Most of patients with drug-resistant seizures demonstrate transient peri-ictal apnea and hypoxemia, especially in the aftermath of a GCS. Experimental and clinical data suggest that most SUDEP primarily result from a fatal seizure-related respiratory arrest. In patients whose SUDEP had occurred during long-term video-EEG monitoring, we observed fatal postictal central apnea after a nocturnal GCS in all SUDEP. Accordingly, it is currently hypothesized that in a subgroup of patients, repetition of seizures may contribute to chronic alteration of respiratory regulation which may increase the risk of fatal postictal central respiratory arrest. Finally, post-mortem data in SUDEP patients showed alteration of neuronal populations involved in respiratory control in the medulla. The complex network that regulates arousal and sleep and the respiratory network are strongly interconnected. Impairment of the interaction between central respiratory control and arousal systems has been reported in several clinical situations, including sleep apnea syndrome, sudden infant death syndrome or Prader-Willi Syndrome. In epilepsy, preclinical data in rodents indirectly support a role for 5HT in the impairment of the interactions between the arousal and respiratory systems in the cascade of events leading to SUDEP. However, no direct evidence is available, and the link between alterations of the brainstem networks involved in arousal regulation and respiratory dysfunction has not been characterized in patients with epilepsy yet.

CONDITIONS

Official Title

Caracterization of the Combined Alterations in Respiration and aROUSal in Patients With Drug-resistant EpiLepsy

Who Can Participate

Age: 18Years - 55Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent obtained and ability to comply with study requirements
  • Aged 18 to 55 years old
  • Diagnosis of focal epilepsy
  • Epilepsy resistant to treatment as defined by International League Against Epilepsy
  • At least 3 focal to bilateral tonic-clonic seizures in the past 18 months
  • Previous long-term video-EEG monitoring for presurgical evaluation within past ten years at Hospices Civils de Lyon
  • Access to detailed information on respiratory dysfunction during seizures and epileptogenic zone localization
  • For healthy subjects: written informed consent and aged 18 to 55 years old
Not Eligible

You will not qualify if you...

  • Ongoing or chronic respiratory or cardiac insufficiency
  • Obstructive sleep-apnea syndrome
  • Treatment with selective serotonin reuptake inhibitors
  • Treatment with vagal nerve stimulation (patients only)
  • Pregnant or breastfeeding women
  • Receiving psychiatric care
  • Deprived of liberty by judicial or administrative decision
  • Adults under legal protection (guardianship, curatorship)
  • Not affiliated with a social security scheme or similar
  • Positive urine pregnancy test at baseline visit if applicable
  • History of epilepsy (healthy subjects only)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Pierre Wertheimer

Bron, Rhone, France, 69500

Actively Recruiting

Loading map...

Research Team

S

Sylvain Pr Rheims

CONTACT

M

Mathilde LECLERCQ

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here